Johnson & Johnson (JNJ) News Headlines

▮ More

Date

Headline

3/19/2020 1:16:38 AM FDA Says No To Epilepsy Drug, IMV Advances COVID-19 Vaccine, ISEE Delays Study

3/17/2020 11:34:34 AM J&J Says No Proof To Support Use Of Darunavir For COVID-19

3/13/2020 10:00:51 AM J&J Collaborates With BIDMC To Accelerate COVID-19 Vaccine Development

3/13/2020 9:44:34 AM Johnson & Johnson Collaborates With Beth Israel Deaconess Medical Center To Accelerate COVID-19 Vaccine Development

2/27/2020 8:36:23 AM Fighting The Deadly Coronavirus

2/18/2020 9:32:41 AM J&J To Expand Partnership With U.S. Health Department To Accelerate Discovery Of Potential COVID-19 Treatments

2/11/2020 4:31:49 PM Janssen To Further Expedite Investigational Coronavirus Vaccine Program Through Expanded Collaboration With BARDA

2/7/2020 12:53:04 PM Johnson & Johnson Ordered To Pay $750 Mln In New Jersey Baby Powder Case

2/7/2020 12:42:54 PM Johnson & Johnson Hit With $750 Mln Punitive Damages Verdict

1/30/2020 9:57:33 PM Johnson & Johnson Ordered To Pay $344 Mln In California Pelvic Mesh Case

1/29/2020 8:51:28 AM Johnson & Johnson Initiates Efforts To Develop A Vaccine Candidate Against 2019-nCoV

1/22/2020 7:32:43 AM Johnson & Johnson Q4 Profit Beats Estimates; Adj. Operational Sales Up 3.4%

1/22/2020 6:35:41 AM Johnson & Johnson Q4 adjusted earnings Beat Estimates

1/22/2020 6:31:47 AM Johnson & Johnson Q4 EPS $1.50; Adj EPS $1.88

1/22/2020 6:07:49 AM Johnson & Johnson Q4 19 Earnings Conference Call At 8:00 AM ET

1/2/2020 6:52:06 AM Johnson & Johnson (JNJ) Declares $ 0.95 Dividend for Q1 20, Record Date 2/25/2020

1/2/2020 6:47:33 AM Johnson & Johnson Announces Q1 Dividend Of $0.95/Shr; Record Feb 25/Payable March 10

12/30/2019 4:07:09 PM Janssen Completes Acquisition Of Investigational Bermekimab From XBiotech

12/20/2019 6:58:16 AM Johnson & Johnson To Acquire Remaining Stake In Verb Surgical - Quick Facts

12/20/2019 6:46:25 AM Johnson & Johnson Agrees To Acquire Remaining Stake In Verb Surgical Inc.